KNSA
Kiniksa Pharmaceuticals Ltd.
$37.01
-$0.28(-0.75%)
45
Overall
40
Value
50
Tech
--
Quality
Market Cap
$2.81B
Volume
481.67K
52W Range
$17.82 - $42.05
Target Price
$50.75
Key Metrics Overview
| Market Cap | $2.81B | P/E Ratio | 38.96 |
| 52W High | $42.05 | 52W Low | $17.82 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 36.1% | 52W Position | 79.2% |
| Overall Score | 45 | Value Score | 40 |
| Quality Score | -- | Technical Score | 50 |
Growth Analysis
| EPS Current Est | $0.95 | EPS Next Est | $1.23 |
| EPS Growth Est | +29.5% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KNSA | $37.01 | -0.8% | 481.67K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kiniksa Pharmaceuticals Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW